Aiocd News Today

AIOCD said that the online medicine business poses a serious threat to public health, serving as a gateway for counterfeit medications in the country. "Weve provided a detailed memorandum outlining these concerns. Allowing it to continue could lead to the monopolisation by big corporations and chains. In the interest of public health and to protect the younger generation from drug abuse, the Government of India should ban E-Pharmacies nationwide," the letter said.

The All India Organisation of Chemists and Druggists (AIOCD) has urged pharmaceutical companies to avoid advertising their products on e-pharmacy platforms, alleging that these platforms operate illegally. In a letter dated November 23, AIOCD stated that certain e-pharmacy platforms violate the Drugs & Cosmetics Act, 1940, and Rules of 1945, defying principles outlined in the Act.

The Drugs Controller General of India (DCGI) on Thursday held fresh consultations with stakeholders on the draft rules to regulate e-pharmacies, amid the Delhi High Court asking the government to inform it about the outcome of deliberations on the draft rules with stakeholders.

The government in February pulled up at least 20 companies, including Tata-1mg, Flipkart, Apollo, PharmEasy

The letter claimed that “ illegally operating e-pharmacies are still in operation after more than 4.5 years.”

Poonawalla Fincorp will extend business loans, loan against property, pre-owned cars, and home loans to AIOCD members

Poonawalla Fincorp will extend business loans, loan against property, pre-owned cars, and home loans to AIOCD members

The framing of trade margins has not been done since 1995, but cost of operations has increased by 150-300 per cent: Singhal

Exclusive content, features, opinions and comment - hand-picked by our editors, just for you. Pick 5 of your favourite companies. Get a daily email with all the news updates on them. Track the industry of your choice with a daily newsletter specific to that industry. Stay on top of your investments. Track stock prices in your portfolio. NOTE : The monthly duration product is an auto renewal based product. Once subscribed, subject to your c...

Dr Reddys Laboratories announced that the companys investee entity i.e. ABCD Technologies LLP (to be renamed as IndoHealth Services LLP) has, through its wholly-owned entity DigiHealth Technologies LLP, acquired 66.02% ownership interest in AIOCD Pharmasofttech Awacs Private (AWACS) though a combination of (i) direct purchase of 50% ownership interest in AWACS and (ii) indirect purchase of 16.02% ownership interest in AWACS through acquisition of 32.04% shareholding interest in Trikaal Mediinf...